 |
PDBsum entry 7mcp
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Inhibitors of bacterial h2s biogenesis targeting antibiotic resistance and tolerance.
|
 |
|
Authors
|
 |
K.Shatalin,
A.Nuthanakanti,
A.Kaushik,
D.Shishov,
A.Peselis,
I.Shamovsky,
B.Pani,
M.Lechpammer,
N.Vasilyev,
E.Shatalina,
D.Rebatchouk,
A.Mironov,
P.Fedichev,
A.Serganov,
E.Nudler.
|
 |
|
Ref.
|
 |
Science, 2021,
372,
1169-1175.
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Emergent resistance to all clinical antibiotics calls for the next generation of
therapeutics. Here we report an effective antimicrobial strategy targeting the
bacterial hydrogen sulfide (H2S)-mediated defense system. We
identified cystathionine γ-lyase (CSE) as the primary generator of
H2S in two major human pathogens, Staphylococcus aureus and
Pseudomonas aeruginosa, and discovered small molecules that inhibit
bacterial CSE. These inhibitors potentiate bactericidal antibiotics against both
pathogens in vitro and in mouse models of infection. CSE inhibitors also
suppress bacterial tolerance, disrupting biofilm formation and substantially
reducing the number of persister bacteria that survive antibiotic treatment. Our
results establish bacterial H2S as a multifunctional defense factor
and CSE as a drug target for versatile antibiotic enhancers.
|
 |
|
|
|
|
 |